David Bouchey
Stock Analyst
(n/a)
# 3,633
Out of 4,648 analysts
6
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Initiates: Buy | $5,200 | $2.88 | +180,769.57% | 1 | Aug 7, 2023 | |
| STSS Sharps Technology | Initiates: Buy | $352 | $2.94 | +11,872.79% | 1 | May 9, 2023 | |
| ATXI Avenue Therapeutics | Initiates: Buy | $2,400 | $2.22 | +107,813.67% | 1 | Apr 3, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $1.30 | +900.85% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $3.96 | +2,959.42% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Aug 7, 2023
Initiates: Buy
Price Target: $5,200
Current: $2.88
Upside: +180,769.57%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $352
Current: $2.94
Upside: +11,872.79%
Avenue Therapeutics
Apr 3, 2023
Initiates: Buy
Price Target: $2,400
Current: $2.22
Upside: +107,813.67%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $1.30
Upside: +900.85%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $3.96
Upside: +2,959.42%